Annual Shareholders Equity
$45.75 M
-$26.17 M-36.38%
December 31, 2023
Summary
- As of February 22, 2025, PRQR annual stockholders equity is $45.75 million, with the most recent change of -$26.17 million (-36.38%) on December 31, 2023.
- During the last 3 years, PRQR annual shareholders equity has fallen by -$24.47 million (-34.84%).
- PRQR annual shareholders equity is now -65.61% below its all-time high of $133.04 million, reached on December 31, 2014.
Performance
PRQR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$27.90 M
-$7.31 M-20.77%
September 1, 2024
Summary
- As of February 22, 2025, PRQR quarterly stockholders equity is $27.90 million, with the most recent change of -$7.31 million (-20.77%) on September 1, 2024.
- Over the past year, PRQR quarterly shareholders equity has dropped by -$21.15 million (-43.12%).
- PRQR quarterly shareholders equity is now -81.29% below its all-time high of $149.17 million, reached on September 30, 2021.
Performance
PRQR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PRQR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.4% | -43.1% |
| 3 y3 years | -34.8% | -56.3% |
| 5 y5 years | -57.0% | -56.3% |
PRQR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.5% | at low | -78.3% | at low |
| 5 y | 5-year | -64.5% | at low | -81.3% | at low |
| alltime | all time | -65.6% | >+9999.0% | -81.3% | >+9999.0% |
ProQR Therapeutics NV Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $27.90 M(-20.8%) |
| Jun 2024 | - | $35.22 M(-6.3%) |
| Mar 2024 | - | $37.60 M(-17.8%) |
| Dec 2023 | $45.75 M(-36.4%) | $45.75 M(-6.7%) |
| Sep 2023 | - | $49.05 M(-12.8%) |
| Jun 2023 | - | $56.28 M(-12.5%) |
| Mar 2023 | - | $64.34 M(-10.5%) |
| Dec 2022 | $71.92 M(-44.2%) | $71.92 M(+12.7%) |
| Sep 2022 | - | $63.81 M(-30.1%) |
| Jun 2022 | - | $91.26 M(-18.9%) |
| Mar 2022 | - | $112.54 M(-12.7%) |
| Dec 2021 | $128.88 M(+83.5%) | $128.88 M(-13.6%) |
| Sep 2021 | - | $149.17 M(+6.1%) |
| Jun 2021 | - | $140.55 M(+141.1%) |
| Mar 2021 | - | $58.30 M(-17.0%) |
| Dec 2020 | $70.22 M(-33.5%) | $70.22 M(-12.8%) |
| Sep 2020 | - | $80.57 M(-10.6%) |
| Jun 2020 | - | $90.08 M(-0.2%) |
| Mar 2020 | - | $90.30 M(-14.5%) |
| Dec 2019 | $105.66 M | $105.66 M(+61.3%) |
| Sep 2019 | - | $65.50 M(-18.4%) |
| Jun 2019 | - | $80.31 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $91.11 M(-14.3%) |
| Dec 2018 | $106.29 M(+125.1%) | $106.29 M(-10.8%) |
| Sep 2018 | - | $119.19 M(+350.7%) |
| Jun 2018 | - | $26.44 M(-27.4%) |
| Mar 2018 | - | $36.43 M(-22.9%) |
| Dec 2017 | $47.22 M(-15.9%) | $47.22 M(+22.4%) |
| Sep 2017 | - | $38.58 M(-8.3%) |
| Jun 2017 | - | $42.08 M(-13.9%) |
| Mar 2017 | - | $48.88 M(-13.0%) |
| Dec 2016 | $56.17 M(-42.8%) | $56.17 M(-18.5%) |
| Sep 2016 | - | $68.92 M(-12.6%) |
| Jun 2016 | - | $78.90 M(-13.2%) |
| Mar 2016 | - | $90.89 M(-7.4%) |
| Dec 2015 | $98.18 M(-26.2%) | $98.18 M(-8.8%) |
| Sep 2015 | - | $107.60 M(-5.6%) |
| Jun 2015 | - | $114.00 M(-4.2%) |
| Mar 2015 | - | $119.05 M(-10.5%) |
| Dec 2014 | $133.04 M(<-9900.0%) | $133.04 M(-5.7%) |
| Sep 2014 | - | $141.10 M(+204.0%) |
| Jun 2014 | - | $46.42 M(<-9900.0%) |
| Dec 2013 | -$122.90 K(-193.9%) | -$122.90 K |
| Dec 2012 | $130.90 K | - |
FAQ
- What is ProQR Therapeutics NV annual stockholders equity?
- What is the all time high annual shareholders equity for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual shareholders equity year-on-year change?
- What is ProQR Therapeutics NV quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly shareholders equity year-on-year change?
What is ProQR Therapeutics NV annual stockholders equity?
The current annual shareholders equity of PRQR is $45.75 M
What is the all time high annual shareholders equity for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual stockholders equity is $133.04 M
What is ProQR Therapeutics NV annual shareholders equity year-on-year change?
Over the past year, PRQR annual stockholders equity has changed by -$26.17 M (-36.38%)
What is ProQR Therapeutics NV quarterly stockholders equity?
The current quarterly shareholders equity of PRQR is $27.90 M
What is the all time high quarterly shareholders equity for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly stockholders equity is $149.17 M
What is ProQR Therapeutics NV quarterly shareholders equity year-on-year change?
Over the past year, PRQR quarterly stockholders equity has changed by -$21.15 M (-43.12%)